替格瑞洛在急性STEMI患者急诊PCI治疗中的疗效及安全性被引量：14

导出

摘要目的观察替格瑞洛在急性ST段抬高型心肌梗死(STEMI)患者急诊PCI治疗中的疗效和安全性。方法随机选择2013年2月至2013年9月急诊行PCI术的急性STEMI患者60例,随机分为两组。30例应用替格瑞洛治疗,30例应用氯吡格雷治疗。观察并比较两组患者术后3个月内主要不良心脏事件(MACE)发生率;出血、呼吸困难及心室间歇并发症的发生率。结果两组患者急诊PCI术后3个月MACE的发生率差异有统计学意义(P<0.05),出血、呼吸困难及心室间歇并发症的发生率差异无统计学意义(P均>0.05)。结论在急性STEMI患者急诊PCI治疗中应用替格瑞洛治疗能够显著改善预后,具有较好的临床效果,且安全性较高。

作者梁鹍董守仁崔红营彭欢

机构地区郑州大学第五附属医院心内三科

出处《中国临床研究》 CAS 2014年第8期937-939,共3页 Chinese Journal of Clinical Research

关键词替格瑞洛氯吡格雷抗血小板急性ST段抬高型心肌梗死经皮冠状动脉介入术

分类号 R542.22 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献14

1Aoki J, Lansky A J, Mehran R, et al. Early stent thrombosis in pa- tients with acute coronary syndromes treated with drug-eluting and bare metal stents : the Acute Catheterization and Urgent Intervention Triage Strategy trial [ J ]. Circulation,2009,119 (5) :687 - 698. 被引量：1
2Hochholzer W,Trenk D, Bestehorn HP, et al. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement [ J ]. J Am Coil Cardiol, 2006,48 ( 9 ) : 1742 - 1750. 被引量：1
3Desai NR, Bhatt DL. The state of periproeedural antiplatelet therapy after recent trials [ J ]. JACC Cardiovasc Interv, 2010,3 ( 6 ) : 571 - 583. 被引量：1
4van Giezen JJ, Humphries RG. Preelinical and clinical studies with selective reversible direct P2Y12 antagonists [ J ]. Semin Thromb Haemost ,2005,31 (2) : 195 - 204. 被引量：1
5Springthorpe B, Bailey A, Barton P, et al. From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis[J]. Bioorg Med Chem Len,2007, 17(21 ) :6013 -6018. 被引量：1
6Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/AHA/ SCAI Guideline for Percutaneous Coronary Intervention: executive summary:a report of the American College of Cardiology Founda- tion/American Heart Association Task Force on Practice Guidelines the Society for Cardiovascular Angiaga'aphy and Interventions [ J ]. Circulation,2011,124 ( 23 ) :2574 - 609. 被引量：1
7Steg G,James SK,Atar D,et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [ J ]. Eur Heart J,2012,33 (20) :2569 - 2619. 被引量：1
8Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelins for the management of patients with ST-elevatian myocardial infar- tion : a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines( Committee to Revise the 1999 Guide-lines for the Management of Patients with Acute My- ocardial Infartion) [ J]. Circulation,20Og, 110(9) :e82 - e92. 被引量：1
9Angiolillo D J, Fernandez-Ortiz A, Bernardo E, et al. Variability in in- dividual responsiveness to clopidogrel:clinical implications, manage- ment,and future perspectives [J]. J Am Coll Cardiol, 2007,49 (14) : 1505 - 1516. 被引量：1
10Gurbel PA, Bliden KP, Butler K, et al. Randomized double-blind as- sessment of the ONSET and OFFSET of the antiplatelet effects of ti- cagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study [ J ]. Circulation, 2009, 120 (25) :2577 -2585. 被引量：1